Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Acadia Pharmaceuticals Inc. ACAD

Set alert

Price alert · ACAD

All alert types
20.75 USD +0.28 +1.36%

As of Nov 3, 10:24 AM ET

Bid
20.74 × 1
Ask
20.76 × 1
20.45 Day range 20.81
18.62 52-week range 30.57
YTD
-22.32%
1 year
-7.25%
Open
20.50
Prev close
20.47
Mkt cap
3.55B
Vol
170.51K
Avg vol
1.87M
EPS
2.23
P/E
9.30
Div yield
0.00%
More statistics
Low
20.45
High
20.81
Forward P/E
22.22
Beta
0.89
Short ratio
3.81
Inst. own
100.05%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
23.74
200-d avg
23.68
1y target
30.53

5D chart

Chart tools
Interval
1m5m15m30m

Signals (119)
NameTimeAgo
SMA: BearishNov 2, 3:55 PM18 hours ago
RSI: OverboughtNov 2, 3:30 PM18 hours ago
SMA: BullishNov 2, 2:25 PM19 hours ago
SMA: BearishNov 2, 2:15 PM20 hours ago
SMA: BullishNov 2, 2:10 PM20 hours ago
MACD: Buy SignalNov 2, 2:00 PM20 hours ago
MACD: Sell SignalNov 2, 1:30 PM20 hours ago
SMA: BearishNov 2, 1:10 PM21 hours ago
SMA: BullishNov 2, 1:05 PM21 hours ago
SMA: BullishNov 2, 1:05 PM21 hours ago
SMA: BearishNov 2, 1:00 PM21 hours ago
SMA: BearishNov 2, 1:00 PM21 hours ago
SMA: BullishNov 2, 12:55 PM21 hours ago
SMA: BullishNov 2, 12:55 PM21 hours ago
SMA: BearishNov 2, 11:55 AM22 hours ago
SMA: BullishNov 2, 11:50 AM22 hours ago
MACD: Buy SignalNov 2, 11:35 AM22 hours ago
SMA: BullishNov 2, 11:30 AM22 hours ago
SMA: BearishNov 2, 10:00 AM1 day ago
SMA: BearishNov 2, 10:00 AM1 day ago

Newest 20 of 119.

Analyst view

Consensus: buy

Buy
Price target (mean) 30.53 +47.1% upside
Target (low)
16.00
Target (mean)
30.53
Target (high)
37.00
Ratings (0m) 20 14 buy · 5 hold · 1 sell
  • Strong buy4
  • Buy10
  • Hold5
  • Sell1
  • Strong sell0

Recommendation trend

  • This month 20
  • 1 month ago 20
  • 2 months ago 21

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ACAD analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.18250.11 – 0.290.42-56.5%332.55M+19.4%14
Next quarter0.209670.14 – 0.250.1375+52.5%361.57M+27.3%13
Current year0.595040.50 – 0.700.8298-28.3%1.27B+18.7%14
Next year0.920720.22 – 1.870.59504+54.7%1.43B+12.4%13

Upgrades and downgrades

The latest rating changes

ACAD analyst upgrades and downgrades
DateFirmActionFromTo
Oct 19, 2026NeedhamReiteratedBuyBuy
Oct 13, 2026UBSDowngradeBuyNeutral
Oct 8, 2026RBC CapitalMaintainedOutperformOutperform
Sep 25, 2026Deutsche BankMaintainedBuyBuy
Sep 25, 2026HC Wainwright & Co.MaintainedBuyBuy
Sep 25, 2026CitizensMaintainedMarket OutperformMarket Outperform
Sep 25, 2026BMO CapitalMaintainedOutperformOutperform
Sep 25, 2026NeedhamMaintainedBuyBuy
Sep 24, 2026CitigroupMaintainedBuyBuy
Sep 24, 2026NeedhamReiteratedBuyBuy
Aug 25, 2026Deutsche BankMaintainedBuyBuy
Aug 25, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Aug 25, 2026CitigroupMaintainedBuyBuy
Aug 17, 2026UBSMaintainedBuyBuy
Aug 12, 2026NeedhamMaintainedBuyBuy
Aug 10, 2026CitigroupMaintainedBuyBuy
Aug 5, 2026OppenheimerMaintainedPerformPerform
Aug 5, 2026RBC CapitalMaintainedOutperformOutperform
Aug 5, 2026CitizensMaintainedMarket OutperformMarket Outperform
Jul 21, 2026BMO CapitalMaintainedOutperformOutperform
Jul 21, 2026StifelMaintainedHoldHold
Jul 7, 2026RBC CapitalMaintainedOutperformOutperform
Jun 30, 2026B of A SecuritiesMaintainedBuyBuy
Jun 29, 2026CitigroupMaintainedBuyBuy
Jun 29, 2026Canaccord GenuityMaintainedBuyBuy
May 8, 2026CitigroupMaintainedBuyBuy
May 7, 2026Canaccord GenuityMaintainedBuyBuy
Mar 25, 2026B of A SecuritiesUpgradeNeutralBuy
Mar 4, 2026JP MorganMaintainedOverweightOverweight
Feb 27, 2026Canaccord GenuityMaintainedBuyBuy